New Data: Efficacy and Responder Analyses of Divigel® (estradiol gel) 0.1 percent for the...
|
RELATED
|
|
iMedExchange Launches Health Policy Resource Center
iMedExchange, the fastest growing social network for physicians, announced today the launch of VitalSigns, a wholly owned family of resources and tools that provides actionable health care policy updates and peer insight on...
WellPoint's Contribution To Drug Formulary Evaluation Standards Highlighted In ISPOR Publication
403 IP Forbidden If you have been redirected to this page, your access to Biocompare has been denied. (If you have stumbled across this page, you can ignore this message.) Please contact Biocompare about the reasons you have...
CombinatoRx and Neuromed Sign Merger Agreement
403 IP Forbidden If you have been redirected to this page, your access to Biocompare has been denied. (If you have stumbled across this page, you can ignore this message.) Please contact Biocompare about the reasons you have...
Omega Medical Solutions Selects Allscripts Practice Management and Allscripts Payerpath Revenue...
Allscripts announced today that Omega Medical Solutions, a Myrtle Beach, SC-based medical billing and consulting agency, has selected Allscripts Practice Management and Allscripts Payerpath(TM) claims management solution for...
Alcon Discontinues Development of Anecortave Acetate for Intraocular Pressure Reduction
403 IP Forbidden If you have been redirected to this page, your access to Biocompare has been denied. (If you have stumbled across this page, you can ignore this message.) Please contact Biocompare about the reasons you have...
UPDATE 1-Novartis Sees FDA Decision on Menveo Early 2010
Novartis (NOVN.VX)said it expects the U.S Food and Drug Administration to rule on the Swiss pharmaceuticals company's Menveo meningitis vaccine in early 2010 after the regulator sought more information about the treatment.
Repros Therapeutics Inc. (RPRX) to Stop Using 50 mg Dose in Fibroids Study
Repros Therapeutics (NasdaqGM:RPRX - News) announced today that an end of Phase II meeting is scheduled with the Food and Drug Administration ("FDA") for late September 2009 to discuss a Phase III program investigating the use...
Proposed 2010 Medicare Fee Schedule Includes A 21.5% Physician Payment Cut
403 IP Forbidden If you have been redirected to this page, your access to Biocompare has been denied. (If you have stumbled across this page, you can ignore this message.) Please contact Biocompare about the reasons you have...
Treating Women in Labor with Allopurinol May Be Useful for Fetal Hypoxia
403 IP Forbidden If you have been redirected to this page, your access to Biocompare has been denied. (If you have stumbled across this page, you can ignore this message.) Please contact Biocompare about the reasons you have...
Study Casts Doubt on Low IQ's Role in Early Death
403 IP Forbidden If you have been redirected to this page, your access to Biocompare has been denied. (If you have stumbled across this page, you can ignore this message.) Please contact Biocompare about the reasons you have...
Related categories
International Editions
English - US | English - UK | Deutsch | Français | Español - España | Português - Portugal | Italiano | Čeština | Русский (Russian) | عربي (Arabic) | 中文（简）(Simplified Chinese) | Español - México | Português - Brasil | 한국어 (Korean) | English - India
